Company Filing History:
Years Active: 2025
Title: Jit Chakravarty: Innovator in Immune Response Modulation
Introduction
Jit Chakravarty is a notable inventor based in Edmond, OK (US). He has made significant contributions to the field of immunology through his innovative research and patent work. His expertise lies in developing small molecule ligands that can effectively modulate immune responses.
Latest Patents
Chakravarty holds a patent for "Aryl hydrocarbon receptor activators." This patent discloses small molecule AhR ligands that can induce the differentiation of Tr1 cells. These ligands are designed to suppress pathogenic immune responses without causing nonspecific immune suppression. Additionally, the patent outlines methods for treating autoimmune diseases using these AhR ligands.
Career Highlights
Jit Chakravarty is affiliated with Oregon State University, where he continues to advance his research in immunology. His work has garnered attention for its potential applications in treating autoimmune conditions, showcasing his commitment to improving health outcomes through scientific innovation.
Collaborations
Chakravarty has collaborated with esteemed colleagues such as Siva Kumar Kolluri and Nancy I Kerkvliet. These partnerships have enriched his research and contributed to the development of his patented technologies.
Conclusion
Jit Chakravarty's innovative work in immune response modulation highlights his role as a significant contributor to the field of immunology. His patent on AhR ligands represents a promising avenue for treating autoimmune diseases, showcasing the impact of his research on future therapeutic strategies.